Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M1,038Revenue (TTM) $M908Net Margin (%)-19.9Altman Z-Score1.0
Enterprise Value $M1,636EPS (TTM) $-2.5Operating Margin %-22.0Piotroski F-Score3
P/E(ttm)--Beneish M-Score-2.0Pre-tax Margin (%)-32.2Higher ROA y-yN
Price/Book1.210-y EBITDA Growth Rate %--Quick Ratio1.6Cash flow > EarningsY
Price/Sales1.15-y EBITDA Growth Rate %-13.4Current Ratio2.1Lower Leverage y-yN
Price/Free Cash Flow11.3y-y EBITDA Growth Rate %-239.5ROA % (ttm)-9.3Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-17.6Less Shares Outstanding y-yY
Payout Ratio %--Shares Outstanding M73.9ROIC % (ttm)-10.0Gross Margin Increase y-yN

Gurus Latest Trades with IPXL

Number of guru portfolios checked: 68.
Ticker Guru Date Action
Impact Price Range
Current Price Change from Average Comment Current Shares

IPXL is held by these investors:

IPXL: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
BENET LESLIE ZDirector 2016-08-15Sell10,092$22.81-38.4view
SCHLOSSBERG MARK ASVP and General Counsel 2015-09-11Sell7,457$43.3-67.55view
NESTOR MICHAELPresident, Impax Pharm. 2015-09-10Sell5,000$43.56-67.75view
FLEMING NIGELDirector 2015-08-31Sell29,166$41.02-65.75view
MARKBREITER MICHAELDirector 2015-08-31Sell28,000$41.7-66.31view
BENET LESLIE ZDirector 2015-08-31Sell20,000$40.92-65.66view
SCHLOSSBERG MARK ASVP and General Counsel 2015-08-27Sell4,649$43.41-67.63view
TERRERI PETER RDirector 2015-08-27Sell4,833$43.93-68.02view
MARKBREITER MICHAELDirector 2015-08-26Sell19,399$42.24-66.74view
HSU LARRYDirector 2014-06-06Sell100,000$28.38-50.49view

Quarterly/Annual Reports about IPXL:

News about IPXL:

Articles On GuruFocus.com
Teva: Good Value, Questionable Management? Jan 02 2017 
Integer Investments: Akorn Has 100% Upside Potential Jan 01 2017 
Sam Isaly Swaps 3 Health Care Stocks in Second Quarter Jul 29 2016 
Kyle Bass Sells Stakes in 11 Health Care Companies Mar 01 2016 
Alan Fournier Makes Modest Reductions in Middleby and Priceline Jan 12 2016 
Allergan Among Health Care Holdings in Alan Fournier's Portfolio Dec 15 2015 
Pharmaceutical Stocks Hold Prominent Positions in Kyle Bass' 3rd-Quarter Activity Nov 27 2015 
Kyle Bass Goes Fishing for These 3 New Holdings Nov 26 2015 
Alan Fournier's Highest Performing Stocks Jul 15 2015 
Alan Fournier's Most Heavily Weighted Trades In Q1 2015 May 28 2015 

More From Other Websites
Zacks.com featured highlights: Applied Materials, General Motors, Citizens Financial Group, Chicago... Feb 22 2017
7 Low Price-to-Cash-Flow Stocks for Assured Returns Feb 21 2017
SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Impax Laboratories, Inc. for... Feb 15 2017
Zacks.com featured highlights: General Motors, Citizens Financial Group, Impax Laboratories and... Feb 06 2017
ETFs with exposure to Impax Laboratories, Inc. : February 3, 2017 Feb 03 2017
7 Stocks You Should Sell Right Now Feb 02 2017
Impax Laboratories, Inc. breached its 50 day moving average in a Bullish Manner : IPXL-US : February... Feb 02 2017
Blog Coverage Pfizer Reported Positive Results for Mid-stage Trial for C. difficile Vaccine Jan 27 2017
Impax to Report Fourth Quarter and Full Year 2016 Results on March 1, 2017 Jan 25 2017
U.S. reaches settlement with Endo on pay-for-delay charges Jan 23 2017
FTC settles pay-for-delay lawsuit, files two related complaints Jan 23 2017
Is Impax a Great Stock for Value Investors? Jan 19 2017
CVS takes on Mylan’s EpiPen with much cheaper version of an alternative Jan 15 2017
Fifth Street Asset Management, Cray, CVS Health, Mylan and Impax Laboratories highlighted as Zacks... Jan 13 2017
Biotech Premarket Movers: SGMO, IPXL, PTLA Jan 13 2017
Cheaper Epinephrine: Spend Way Less With This EpiPen Alternative Jan 12 2017
UPDATE 1-CVS slashes price of Impax's EpiPen rival Jan 12 2017
CVS slashes price of Impax's emergency allergy shot Jan 12 2017
Mylan Crushed by Trump, Cigna and CVS -- All In Two Days Jan 12 2017
[$$] Cigna Drops EpiPen Coverage for Generic Jan 12 2017

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)